PROPANC BIOPHARMA, INC. Income (Loss) from Continuing Operations before Income Taxes, Domestic
PROPANC BIOPHARMA, INC. (PPCB) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$855.44 thousand for the 3-month period ending 2021-12-31, per its 10-Q filed 2022-02-14.
Discontinued › Income Statement
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2022-02-14
- PROPANC BIOPHARMA, INC. income (loss) from continuing operations before income taxes, domestic for the quarter ending 2021-12-31 was -$855.44K.
- PROPANC BIOPHARMA, INC. income (loss) from continuing operations before income taxes, domestic for the quarter ending 2021-09-30 was -$490.66K.
- PROPANC BIOPHARMA, INC. income (loss) from continuing operations before income taxes, domestic for the quarter ending 2021-03-31 was -$530.01K.
- PROPANC BIOPHARMA, INC. income (loss) from continuing operations before income taxes, domestic for the quarter ending 2020-12-31 was -$403.64K.
- PROPANC BIOPHARMA, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2020 was -$4.88M.
- PROPANC BIOPHARMA, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2019 was -$5.87M.
- PROPANC BIOPHARMA, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2018 was -$7.22M.
- PROPANC BIOPHARMA, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2017 was -$8.17M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 3 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 6 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 9 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 51 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 54 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 57 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 60 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 63 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 66 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 68 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 72 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 75 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 77 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-31 | -$855.44K 10-Q · filed 2022-02-14 | -$1.35M 10-Q · filed 2022-02-14 | ||||||||||||
| 2021-09-30 | -$490.66K 10-Q · filed 2021-11-12 | |||||||||||||
| 2021-03-31 | -$530.01K 10-Q · filed 2021-05-14 | -$933.66K derived: sum of 2 quarters · filed 2022-02-14 | -$1.36M 10-Q · filed 2021-05-14 | -$154.88K derived: sum of 4 quarters · filed 2022-02-14 | ||||||||||
| 2020-12-31 | -$403.64K 10-Q · filed 2022-02-14 | -$829.19K 10-Q · filed 2022-02-14 | $375.14K derived: sum of 3 quarters · filed 2022-02-14 | -$2.24M derived: sum of 4 quarters · filed 2022-02-14 | ||||||||||
| 2020-09-30 | -$425.55K 10-Q · filed 2021-11-12 | $778.78K derived: sum of 2 quarters · filed 2021-11-12 | -$1.83M derived: sum of 3 quarters · filed 2021-11-12 | -$3.70M derived: sum of 4 quarters · filed 2021-11-12 | ||||||||||
| 2020-06-30 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-01 | -$1.41M derived: sum of 2 quarters · filed 2021-05-14 | -$3.27M derived: sum of 3 quarters · filed 2021-05-14 | -$4.88M 10-K · filed 2020-10-01 | ||||||||||
| 2020-03-31 | -$2.61M 10-Q · filed 2021-05-14 | -$4.48M derived: sum of 2 quarters · filed 2021-05-14 | -$6.08M 10-Q · filed 2021-05-14 | -$7.68M derived: sum of 4 quarters · filed 2021-05-14 | ||||||||||
| 2019-12-31 | -$1.87M 10-Q · filed 2021-02-12 | -$3.47M 10-Q · filed 2021-02-12 | -$5.07M derived: sum of 3 quarters · filed 2021-02-12 | -$5.65M derived: sum of 4 quarters · filed 2021-02-12 | ||||||||||
| 2019-09-30 | -$1.60M 10-Q · filed 2020-11-16 | -$3.20M derived: sum of 2 quarters · filed 2020-11-16 | -$3.78M derived: sum of 3 quarters · filed 2020-11-16 | -$5.35M derived: sum of 4 quarters · filed 2020-11-16 | ||||||||||
| 2019-06-30 | -$1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-01 | -$2.18M derived: sum of 2 quarters · filed 2020-10-01 | -$3.75M derived: sum of 3 quarters · filed 2020-10-01 | -$5.87M 10-K · filed 2020-10-01 | ||||||||||
| 2019-03-31 | -$581.13K 10-Q · filed 2020-05-15 | -$2.15M derived: sum of 2 quarters · filed 2020-05-15 | -$4.27M 10-Q · filed 2020-05-15 | -$5.69M derived: sum of 4 quarters · filed 2020-05-15 | ||||||||||
| 2018-12-31 | -$1.57M 10-Q · filed 2020-02-14 | -$3.69M 10-Q · filed 2020-02-14 | -$5.11M derived: sum of 3 quarters · filed 2020-02-14 | -$6.60M derived: sum of 4 quarters · filed 2020-02-14 | ||||||||||
| 2018-09-30 | -$2.12M 10-Q · filed 2019-11-14 | -$3.55M derived: sum of 2 quarters · filed 2019-11-14 | -$5.04M derived: sum of 3 quarters · filed 2019-11-14 | -$7.42M derived: sum of 4 quarters · filed 2019-11-14 | ||||||||||
| 2018-06-30 | -$1.42M derived: 10-K 12 month − 10-Q 9 month · filed 2019-10-15 | -$2.91M derived: sum of 2 quarters · filed 2019-10-15 | -$5.29M derived: sum of 3 quarters · filed 2019-10-15 | -$7.22M 10-K · filed 2019-10-15 | ||||||||||
| 2018-03-31 | -$1.49M 10-Q · filed 2019-05-15 | -$3.87M derived: sum of 2 quarters · filed 2019-05-15 | -$5.80M 10-Q · filed 2019-05-15 | -$7.43M derived: sum of 4 quarters · filed 2019-05-15 | ||||||||||
| 2017-12-31 | -$2.38M 10-Q · filed 2019-02-14 | -$4.31M 10-Q · filed 2019-02-14 | -$5.94M derived: sum of 3 quarters · filed 2019-02-14 | -$7.62M derived: sum of 4 quarters · filed 2019-02-14 | ||||||||||
| 2017-09-30 | -$1.92M 10-Q · filed 2018-11-13 | -$3.56M derived: sum of 2 quarters · filed 2018-11-13 | -$5.23M derived: sum of 3 quarters · filed 2018-11-13 | -$8.99M derived: sum of 4 quarters · filed 2018-11-13 | ||||||||||
| 2017-06-30 | -$1.63M derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-17 | -$3.31M derived: sum of 2 quarters · filed 2018-09-17 | -$7.07M derived: sum of 3 quarters · filed 2018-09-17 | -$8.17M 10-K · filed 2018-09-17 | ||||||||||
| 2017-03-31 | -$1.68M 10-Q · filed 2018-05-10 | -$5.44M derived: sum of 2 quarters · filed 2018-05-10 | -$6.54M 10-Q · filed 2018-05-10 | -$9.40M derived: sum of 4 quarters · filed 2018-05-10 | ||||||||||
| 2016-12-31 | -$3.76M 10-Q · filed 2018-02-09 | -$4.86M 10-Q · filed 2018-02-09 | -$7.72M derived: sum of 3 quarters · filed 2018-02-09 | -$9.87M derived: sum of 4 quarters · filed 2018-02-09 | ||||||||||
| 2016-09-30 | -$1.10M 10-Q · filed 2017-11-09 | -$3.96M derived: sum of 2 quarters · filed 2017-11-09 | -$6.11M derived: sum of 3 quarters · filed 2017-11-09 | -$9.75M derived: sum of 4 quarters · filed 2017-11-09 | ||||||||||
| 2016-06-30 | -$2.86M derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-28 | -$5.01M derived: sum of 2 quarters · filed 2017-09-28 | -$8.64M derived: sum of 3 quarters · filed 2017-09-28 | -$9.48M 10-K · filed 2017-09-28 | ||||||||||
| 2016-03-31 | -$2.15M 10-Q · filed 2017-05-08 | -$5.79M derived: sum of 2 quarters · filed 2017-05-08 | -$6.62M 10-Q · filed 2017-05-08 | -$8.45M derived: sum of 4 quarters · filed 2017-05-08 | ||||||||||
| 2015-12-31 | -$3.63M 10-Q · filed 2017-02-14 | -$4.47M 10-Q · filed 2017-02-14 | -$6.30M derived: sum of 3 quarters · filed 2017-02-14 | -$6.75M derived: sum of 4 quarters · filed 2017-02-14 | ||||||||||
| 2015-09-30 | -$838.89K 10-Q · filed 2016-11-10 | -$2.66M derived: sum of 2 quarters · filed 2016-11-10 | -$3.12M derived: sum of 3 quarters · filed 2016-11-10 | -$3.55M derived: sum of 4 quarters · filed 2016-11-10 | ||||||||||
| 2015-06-30 | -$1.82M derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-28 | -$2.28M derived: sum of 2 quarters · filed 2016-09-28 | -$2.71M derived: sum of 3 quarters · filed 2016-09-28 | -$3.49M 10-K · filed 2016-09-28 | ||||||||||
| 2015-03-31 | -$454.25K 10-Q · filed 2016-05-16 | -$882.17K derived: sum of 2 quarters · filed 2016-05-16 | -$1.67M 10-Q · filed 2016-05-16 | -$1.88M derived: sum of 4 quarters · filed 2016-05-16 | ||||||||||
| 2014-12-31 | -$427.92K 10-Q · filed 2016-02-16 | -$1.21M 10-Q · filed 2016-02-16 | -$1.43M derived: sum of 3 quarters · filed 2016-02-16 | -$1.50M derived: sum of 4 quarters · filed 2016-02-16 | ||||||||||
| 2014-09-30 | -$783.30K 10-Q · filed 2015-11-16 | -$1.00M derived: sum of 2 quarters · filed 2015-11-16 | -$1.07M derived: sum of 3 quarters · filed 2015-11-16 | -$1.09M derived: sum of 4 quarters · filed 2015-11-16 | ||||||||||
| 2014-06-30 | -$217.84K derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-30 | -$284.71K derived: sum of 2 quarters · filed 2015-09-30 | -$306.76K derived: sum of 3 quarters · filed 2015-09-30 | -$877.83K 10-K · filed 2015-09-30 | ||||||||||
| 2014-03-31 | -$66.86K 10-Q · filed 2015-05-15 | -$88.92K derived: sum of 2 quarters · filed 2015-05-15 | -$659.99K 10-Q · filed 2015-05-15 | -$884.39K derived: sum of 4 quarters · filed 2015-05-15 | -$17.70M 10-Q · filed 2014-05-20 | |||||||||
| 2013-12-31 | -$22.05K 10-Q · filed 2015-02-17 | -$593.56K 10-Q · filed 2015-02-17 | -$817.52K derived: sum of 3 quarters · filed 2015-02-17 | -$1.16M derived: sum of 4 quarters · filed 2015-02-17 | -$17.64M 10-Q · filed 2014-02-14 | |||||||||
| 2013-09-30 | -$571.51K 10-Q · filed 2014-11-19 | -$795.47K derived: sum of 2 quarters · filed 2014-11-19 | -$1.13M derived: sum of 3 quarters · filed 2014-11-19 | -$1.58M derived: sum of 4 quarters · filed 2014-11-19 | -$17.61M 10-Q · filed 2013-11-14 | |||||||||
| 2013-06-30 | -$223.96K derived: 10-K 12 month − 10-Q 9 month · filed 2014-10-14 | -$561.66K derived: sum of 2 quarters · filed 2014-10-14 | -$1.01M derived: sum of 3 quarters · filed 2014-10-14 | -$1.50M 10-K · filed 2014-10-14 | -$17.04M 10-K · filed 2013-10-15 | |||||||||
| 2013-03-31 | -$337.70K 10-Q · filed 2014-05-20 | -$786.58K derived: sum of 2 quarters · filed 2014-05-20 | -$1.28M 10-Q · filed 2014-05-20 | -$3.84M derived: sum of 4 quarters · filed 2014-05-20 | -$16.82M 10-Q · filed 2013-05-20 | |||||||||
| 2012-12-31 | -$448.87K 10-Q · filed 2014-02-14 | -$941.44K 10-Q · filed 2014-02-14 | -$3.50M derived: sum of 3 quarters · filed 2014-02-14 | -$6.60M derived: sum of 4 quarters · filed 2014-02-14 | -$16.48M 10-Q · filed 2013-02-20 | |||||||||
| 2012-09-30 | -$492.68K 10-Q · filed 2013-11-14 | -$3.05M derived: sum of 2 quarters · filed 2013-11-14 | -$6.15M derived: sum of 3 quarters · filed 2013-11-14 | -$9.03M derived: sum of 4 quarters · filed 2013-11-14 | -$16.03M 10-Q · filed 2012-11-19 | |||||||||
| 2012-06-30 | -$2.56M derived: 10-K 12 month − 10-Q 9 month · filed 2013-10-15 | -$5.65M derived: sum of 2 quarters · filed 2013-10-15 | -$8.54M derived: sum of 3 quarters · filed 2013-10-15 | -$11.61M 10-K · filed 2013-10-15 | -$15.54M 10-K · filed 2012-10-15 | |||||||||
| 2012-03-31 | -$3.10M 10-Q · filed 2013-05-20 | -$5.98M derived: sum of 2 quarters · filed 2013-05-20 | -$9.05M 10-Q · filed 2013-05-20 | -$9.71M derived: sum of 4 quarters · filed 2013-05-20 | -$12.98M 10-Q · filed 2012-05-21 | |||||||||
| 2011-12-31 | -$2.88M 10-Q · filed 2013-02-20 | -$5.96M 10-Q · filed 2013-02-20 | -$6.61M derived: sum of 3 quarters · filed 2013-02-20 | -$7.12M derived: sum of 4 quarters · filed 2013-02-20 | -$9.89M 10-Q/A · filed 2012-03-07 | |||||||||
| 2011-09-30 | -$3.07M 10-Q · filed 2012-11-19 | -$3.73M derived: sum of 2 quarters · filed 2012-11-19 | -$4.24M derived: sum of 3 quarters · filed 2012-11-19 | -$4.73M derived: sum of 4 quarters · filed 2012-11-19 | ||||||||||
| 2011-06-30 | -$655.72K derived: 10-K 12 month − 10-Q 9 month · filed 2012-10-15 | -$1.16M derived: sum of 2 quarters · filed 2012-10-15 | -$1.66M derived: sum of 3 quarters · filed 2012-10-15 | -$2.24M 10-K · filed 2012-10-15 | ||||||||||
| 2011-03-31 | -$508.44K 10-Q · filed 2012-05-21 | -$1.00M derived: sum of 2 quarters · filed 2012-05-21 | -$1.58M 10-Q · filed 2012-05-21 | |||||||||||
| 2010-12-31 | -$492.12K 10-Q/A · filed 2012-03-07 | -$1.12M 10-Q/A · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |